CLDX CELLDEX THERAPEUTICS INC Investments/Divestments 8-K Filing 2024 - Investment Offering Celldex Therapeutics, Inc. entered into an underwriting agreement for the offering, issuance, and sale of 8,520,000 shares of common stock at a price of $47.00 per share, with expected net proceeds of approximately $376.2 million.Get access to all SEC 8-K filings of the CELLDEX THERAPEUTICS INC